This company is offering Merifluor Chlamydia/RSV/VZV/CMV fluorescent monoclonal antibody reagents for rapid antigen detection. The chlamydia test has been developed to provide detection of known serotypes of C. trachomatis and C. psittaci in cell culture. The CMV test features pre-CPE identification to provide earlier detection of cytomegalovirus in cell culture. This test has 94 to 97 percent sensitivity and 100 percent specificity.
The VZV test directly detects Varicella-Zoster Virus in visicle smears, biopsy specimens, and cell culture. It also features specific differentiation of VZV from Herpes Simplex Virus or Cytomegalovirus.
The RSV test can accurately detect Respiratory Syncytial Virus directly from nasopharyngeal specimens and cell culture. The procedure does not require viable organisms. Meridian Diagnostics
